Cargando…

Genome-proteome system for prostate cancer

Detalles Bibliográficos
Autor principal:	Peshkov, Maxim N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125923/ http://dx.doi.org/10.1186/1878-5085-5-S1-A28

Ejemplares similares

Genomic and proteomic characterization of multi-drug resistant Acinetobacter baumannii
por: Marshall, Dana, et al.
Publicado: (2013)

Translational research to practice for gastric cancer: molecular classification and outcome prediction based on genomic and proteomic profiling
por: Lv, Youyong, et al.
Publicado: (2012)

Bioinformatic challenges for proteomic biomarkers of cancer
por: Tabb, David L, et al.
Publicado: (2011)

The road to linking genomics and proteomics of pathogenic bacteria: from binary protein complexes to interaction pathways
por: Keasey, Sarah L, et al.
Publicado: (2015)

Progress in clinical genetics of prostate cancer
por: Cybulski, C, et al.
Publicado: (2011)

Prostatic mapping in diagnosis and follow-up for prostatic cancer patients treated by CT-RT
por: Azzarello, Guido, et al.
Publicado: (2009)

DNA testing for high risk of prostate cancer
por: Wokołorczyk, Dominika
Publicado: (2012)

NBS1 Mutation and prognosis of prostate cancer
por: Wokołorczyk, Dominika, et al.
Publicado: (2012)

HOXB13 mutations and prostate cancer in Poland
por: Kluźniak, Wojciech, et al.
Publicado: (2012)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Interaction of prostate cancer and neurons – the neuro-neoplastic synapse
por: Voss, MJ, et al.
Publicado: (2009)

Mining the human proteome for conserved mechanisms
por: Naulaerts, Stefan, et al.
Publicado: (2015)

Serum levels of markers in early detection of prostate cancer (pilote study)
por: Fuchsova, Radka, et al.
Publicado: (2014)

RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers
por: Deb, S, et al.
Publicado: (2012)

Prostate cancer screening based on genotyping for high risk founder alleles
por: Cybulski, Cezary, et al.
Publicado: (2012)

SLE: insights from array-based proteomics
por: Wu, T, et al.
Publicado: (2012)

Systemic therapy for hereditary cancer
por: Imyanitov, Evgeny N
Publicado: (2012)

Integrative proteomics and genomics supports a role for interferon gamma in the pathogenesis of Kaposi sarcoma and finds multiple candidate diagnostic proteins for early detection or prevention
por: Amon, Lynn, et al.
Publicado: (2010)

Proteomic profiling of secretory granules of different T cell subpopulations
por: Schmidt, H, et al.
Publicado: (2009)

Focal MR-guided focused ultrasound treatment of localized low-risk prostate cancer
por: Nosov, Alexandr, et al.
Publicado: (2014)

Heme oxygenase-1 activation inhibits XMRV pathogenesis and carcinogenesis in prostate cancer cells
por: Dhawan, Subhash
Publicado: (2011)

Development of a proteomic platform for EBV and KSHV serological screening
por: Wang, Leyao, et al.
Publicado: (2010)

The antibiotic resistance proteome of Acinetobacter baumanii MDR isolate MMC#4
por: Marshall, Dana, et al.
Publicado: (2012)

Biobanks and cancer genome projects in China
por: Lv, Youyong
Publicado: (2012)

Genomic imbalance in endometrial hyperplasia and cancer
por: Bednarek, Michal, et al.
Publicado: (2015)

Comparative proteomic analysis of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma
por: Suzuki, Tadaki, et al.
Publicado: (2011)

The effects of XMRV gene expression on the mouse prostate
por: Rauch, Daniel, et al.
Publicado: (2011)

Patterns of cytokines and lymphocyte subsets in patients with breast and prostate cancer treated with a standardized mistletoe extract preparation
por: Wetzel, D, et al.
Publicado: (2001)

Proteomic and metabolomic characterization of CHO DP-12 cell lines with different high passage histories
por: Beckmann, Tim, et al.
Publicado: (2011)

Lung cancer in systemic lupus erythematosus
por: Kale, M, et al.
Publicado: (2012)

Imaging patients with breast and prostate cancers using combined 18F NaF/18F FDG and TOF simultaneous PET/ MRI
por: Iagaru, Andrei, et al.
Publicado: (2015)

Integrated genomic analysis and functional characterisation of novel oncogenes in ovarian cancer
por: Davis, SJ, et al.
Publicado: (2012)

Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis
por: Sawyer, S, et al.
Publicado: (2012)

Opportunities of predictive medicine at the treatment of diabetes mellitus complications
por: Sautin, Maxim, et al.
Publicado: (2014)

Copper transport system and response to ovarian cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

A short tutorial in analyzing NGS data of cancer genomes for somatic mutation calling
por: Vuong, Huy, et al.
Publicado: (2013)

Genomic and proteomic techniques applied to reproductive biology
por: Rockett, John C
Publicado: (2001)

Genomics, proteomics and bioinformatics: all in the same boat
por: Russell, Robert B
Publicado: (2002)

Prof. Eric A. Klein: genomic research in prostate cancer
por: Xu, Eunice X.
Publicado: (2016)

Dr. Jeffrey Tomaszewski: the application of prostate cancer genomic tests
por: Gao, Skylar
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2ept31es0nefjll0vnn9f39lrj